Histocell SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Histocell SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10928
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, among others. Its wharton gel complex is a cosmetic ingredient with skin protective and regenerative properties. Histocell develops, manufactures and sells medical devices and drugs such as Cicatrigel, Histogel and Histobone, among others. The company also provides biocompatibility tests, advanced molecular and cellular biology analytical services and biological research services. Histocell is headquartered in Derio, Spain.

Histocell SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Histocell SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Histocell SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Histocell SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Histocell SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Histocell SL, Medical Devices Deals, 2012 to YTD 2018 9
Histocell SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Histocell SL, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Histocell Enters Into Co-Development Agreement With Ferrer 11
Licensing Agreements 12
Luqa Pharma Enters into Licensing Agreement with Histocell for Reoxcare 12
Histocell Enters Into Licensing Agreement With IDIBELL For Acute Pulmonary Diseases Patent 13
Histocell SL – Key Competitors 14
Histocell SL – Key Employees 15
Histocell SL – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Histocell SL, Pharmaceuticals & Healthcare, Key Facts 2
Histocell SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Histocell SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Histocell SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Histocell SL, Deals By Therapy Area, 2012 to YTD 2018 8
Histocell SL, Medical Devices Deals, 2012 to YTD 2018 9
Histocell SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Histocell Enters Into Co-Development Agreement With Ferrer 11
Luqa Pharma Enters into Licensing Agreement with Histocell for Reoxcare 12
Histocell Enters Into Licensing Agreement With IDIBELL For Acute Pulmonary Diseases Patent 13
Histocell SL, Key Competitors 14
Histocell SL, Key Employees 15
Histocell SL, Joint Venture 16

List of Figures
Histocell SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Histocell SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Histocell SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Histocell SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Histocell SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Histocell SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Histocell SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Histocell SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Histocell SL, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Histocell SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sulzer Ltd (SUN):企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglyc …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Desitin Arzneimittel GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Desitin Arzneimittel GmbH (Desitin), formerly Desitin Compagnie mbH is a healthcare products provider that offers therapeutic products. The company develops and markets products for the treatment of neurological and psychiatric illnesses. It provides products for various therapeutic areas su …
  • Sandvik AB (SAND):企業の財務・戦略的SWOT分析
    Sandvik AB (SAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cathedral Energy Services Ltd (CET):石油・ガス:M&Aディール及び事業提携情報
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, measurement while drilling services, production testing services, …
  • IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • Oncternal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company’s pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BEENOS Inc.:企業のM&A・事業提携・投資動向
    BEENOS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BEENOS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Progenics Pharmaceuticals Inc (PGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Progenics Pharmaceuticals Inc (Progenics) is a late-stage biopharmaceutical company that focuses on developing medicines and products for the treatment of cancer and related conditions. Its only commercial product, Relistor, is used for the treatment of opioid-induced constipation. The compa …
  • Bioceros BV-製薬・医療分野:企業M&A・提携分析
    Summary Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and proc …
  • Boubyan Petrochemical Co:企業の戦略・SWOT・財務分析
    Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report Summary Boubyan Petrochemical Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Findel plc:企業の戦略・SWOT・財務情報
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • Labrador Iron Mines Holdings Limited:企業の戦略・SWOT・財務情報
    Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆